These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1377955)

  • 1. Studies on the mechanism of binding of serpins and serine proteases.
    Longstaff C; Gaffney PJ
    Blood Coagul Fibrinolysis; 1992 Feb; 3(1):89-97. PubMed ID: 1377955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serpin-serine protease binding kinetics: alpha 2-antiplasmin as a model inhibitor.
    Longstaff C; Gaffney PJ
    Biochemistry; 1991 Jan; 30(4):979-86. PubMed ID: 1703440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of soluble fibrin on reaction kinetics of plasmin type 1 and type 2 with alpha2-antiplasmin.
    Ries M; Zenker M
    Blood Coagul Fibrinolysis; 2003 Feb; 14(2):203-9. PubMed ID: 12632033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors.
    Walker JB; Bajzar L
    J Thromb Haemost; 2007 Jun; 5(6):1257-64. PubMed ID: 17389009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of alpha 2-antiplasmin as a model for the demonstration of complex reversibility in serpins.
    Shieh BH; Potempa J; Travis J
    J Biol Chem; 1989 Aug; 264(23):13420-3. PubMed ID: 2474530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Features of the interaction between alpha2-antiplasmin and plasminogen/plasmin].
    Hrynenko TV; Iusova OI; Zadorozhna MB; Makohonenko IeM
    Ukr Biokhim Zh (1999); 2002; 74(6):83-90. PubMed ID: 12924019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the reaction of plasmin or plasmin-streptokinase complex with aprotinin or alpha 2-antiplasmin.
    Wiman B
    Thromb Res; 1980 Jan 1-15; 17(1-2):143-52. PubMed ID: 6154981
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of the antiplasmin activity of human thrombospondin-1 in solution.
    Anonick PK; Yoo JK; Webb DJ; Gonias SL
    Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):903-9. PubMed ID: 7679575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of the modified form of human plasminogen by alpha 2-macroglobulin-plasmin complexes.
    Yamamoto J; Okamoto U; Morita S; Asada N; Yamaoka M
    Jpn J Physiol; 1985; 35(6):1013-21. PubMed ID: 2422420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
    Edelberg JM; Pizzo SV
    Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: specific role of the plasminogen-binding form of alpha 2-antiplasmin.
    Leebeek FW; Kluft C; Knot EA; Los P; Cohen AF; Six AJ
    J Am Coll Cardiol; 1990 May; 15(6):1212-20. PubMed ID: 1691750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of plasmin and its complexes with alpha 2-antiplasmin and alpha 2-macroglobulin on secretion of proteinase and plasminogen inhibitors from peripheral mononuclear cells].
    Zhabin SG; Zorin NA; Musatov MI
    Vopr Med Khim; 1995; 41(3):34-7. PubMed ID: 8585176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
    Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
    Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of the reactions between streptokinase, plasmin and alpha 2-antiplasmin.
    Cederholm-Williams SA; De Cock F; Lijnen HR; Collen D
    Eur J Biochem; 1979 Oct; 100(1):125-32. PubMed ID: 158524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cell surface receptor-bound plasmin by alpha 2-antiplasmin and alpha 2-macroglobulin.
    Hall SW; Humphries JE; Gonias SL
    J Biol Chem; 1991 Jul; 266(19):12329-36. PubMed ID: 1712017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of chymotrypsin and human skin chymase: kinetics of time-dependent inhibition in the presence of substrate.
    Johnson LA; Moon KE; Eisenberg M
    Biochim Biophys Acta; 1988 Apr; 953(3):269-79. PubMed ID: 2451541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reaction of human alpha2-antiplasmin and plasmin stopped-flow fluorescence kinetics.
    Christensen U; Bangert K; Thorsen S
    FEBS Lett; 1996 May; 387(1):58-62. PubMed ID: 8654567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of a slow and tight-binding inhibitor of plasmin isolated from Russell's viper venom.
    Cheng AC; Tsai IH
    Biochim Biophys Acta; 2014 Jan; 1840(1):153-9. PubMed ID: 23999090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-2-antiplasmin: a serpin with two separate but overlapping reactive sites.
    Potempa J; Shieh BH; Travis J
    Science; 1988 Aug; 241(4866):699-700. PubMed ID: 2456616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of plasmin, miniplasmin, and streptokinase-plasmin complex by alpha 2-antiplasmin, alpha 2-macroglobulin, and antithrombin III in the presence of heparin.
    Anonick PK; Wolf B; Gonias SL
    Thromb Res; 1990 Aug; 59(3):449-62. PubMed ID: 1700488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.